Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its once-monthly double GLP-1/ GIP receptor agonist, finishing (PDF) progress...

Daiichi spends Merck $170M to create lung cancer T-cell engager deal

.Merck &amp Co. has actually quickly recovered some of the prices of its own Harpoon Rehabs buyout, ...

BioMarin standstills preclinical genetics therapy for heart disease

.After BioMarin performed a spring clean of its own pipe in April, the firm has decided that it addi...

Eisai vegetations molecular adhesive SEED along with $1.5 B biobucks handle

.Large Pharmas continue to be stuck to the suggestion of molecular adhesive degraders. The current c...

Life science credit rating firm introduces along with $600M

.A brand-new international life science credit score firm, referred to Symbiotic Funding, has actual...

BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another huge wager from the Caforio time, canceling a ba...

Nuvation halts wager inhibitor after taking into consideration period 1 data

.After looking at period 1 data, Nuvation Bio has chosen to halt service its own single lead BD2-sel...

' Clinical instinct' led FDA consultants to support Zevra's unusual illness med

.Zevra Rehabs' uncommon health condition drug appears to become on the course to approval this autum...

Pfizer takes $230M attacked after axing stopped working DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene therapy failure has actually blown a $230 mil...

AC Immune views 'landmark' potential in Alzheimer's drug data

.After more than 20 years of deal with neurodegenerative illness, Swiss biotech air conditioning Imm...